专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明申请

WO2006003163A1 SOLID FORMS OF THE MAGNESIUM SALT OF (S)-OMEPRAZOLE AND PROCESSES FOR THEIR PREPARATION 审中-公开
标题翻译：（S） - 吡咯的镁盐的固体形式及其制备方法
公开(公告)号：WO2006003163A1
公开(公告)日：2006-01-12
申请号：PCT/EP2005/053062
申请日：2005-06-29
申请人： ESTEVE QUÍMICA, S.A. , BERENGUER MAIMO, Ramón , COPPI, Laura , GASANZ GUILLÉN, Yolanda , MEDRANO RUPÉREZ, Jorge
发明人： BERENGUER MAIMO, Ramón , COPPI, Laura , GASANZ GUILLÉN, Yolanda , MEDRANO RUPÉREZ, Jorge
IPC分类号： C07D401/12
CPC分类号： C07D401/12
摘要： New solid forms of the active ingredient magnesium salt of S-omeprazole, obtainable by a preparation process that comprises: a) crystallizing a magnesium salt of S-omeprazole from a solution of a magnesium salt of S- omeprazole in a solvent system that comprises a mixture of methanol/water with an amount of water equal to or greater than 0,01 ml/g of the magnesium salt of S-omeprazole starting material; b) isolating the magnesium salt of S- omeprazole that appears in the prior step; c) separating the free organic solvent from the magnesium salt of S-omeprazole obtained or, alternatively, separating both the free solvent and the solvation solvent. The new solid forms are obtained by a reproducible and robust process, with high yield and elevated optical purity, which is useful for the preparation of pharmaceutical products that contain said active ingredient.
摘要翻译： S-奥美拉唑的活性成分镁盐的新固体形式，其可通过制备方法获得，所述制备方法包括：a）将S-奥美拉唑的镁盐从S-奥美拉唑的镁盐溶液在包含甲醇/水的混合物，其量为等于或大于0.01ml / g的S-奥美拉唑原料的镁盐; b）分离出先前步骤中的S-奥美拉唑的镁盐; c）从所获得的S-奥美拉唑的镁盐中分离游离有机溶剂，或者分离游离溶剂和溶剂化溶剂两者。新的固体形式通过可重复且可靠的方法获得，具有高产率和高的光学纯度，其可用于制备含有所述活性成分的药物产品。

32. 发明申请

WO2006000551A1 PRODUCT OF VEGETAL ORIGIN COMPRISING PROANTHOCYANIDINES AND ITS PREPARATION PROCESS 审中-公开
标题翻译：含有蒽醌类化合物的植物原产物及其制备方法
公开(公告)号：WO2006000551A1
公开(公告)日：2006-01-05
申请号：PCT/EP2005/052877
申请日：2005-06-21
申请人： INVESTIGACION Y NUTRICION, S.L. , RUIZ-ROSO CALVO DE MORA, Baltasar , REQUEJO MARCOS, Ana María , PEREZ-OLLEROS CONDE, Lourdes , HOLGUIN HUESO, José Antonio
发明人： RUIZ-ROSO CALVO DE MORA, Baltasar , REQUEJO MARCOS, Ana María , PEREZ-OLLEROS CONDE, Lourdes , HOLGUIN HUESO, José Antonio
IPC分类号： A61K35/78
CPC分类号： A61K36/752 , A61K36/48 , A61K2300/00
摘要： Product of vegetal origin with a high percentage of proanthocyanidines with molecular weight superior to 6000 daltons, a very high percentage of said proanthocyanidines has a molecular weight superior to 30000 daltons, which produces a great hypocholesterolaemic effect at acceptable doses for human consume and little astringent and anti-nutritional effects. The product of vegetal origin can be presented as medicine, pharmaceutical composition, dietary complement or food product. An industrial process is provided for its preparation from dicotyledons.
摘要翻译：分子量高于6000道尔顿的原花青素含量高的植物来源的产品，非常高比例的所述原花青素具有优于30000道尔顿的分子量，其在可接受的剂量下对人体消耗和少量涩味产生较大的降胆固醇血症作用，抗营养作用。植物来源的产品可以作为药物，药物组合物，膳食补充剂或食品。提供了从双子叶植物制备工业过程。

33. 发明申请

WO2005044408A1 SYSTEM AND METHOD FOR SIMULATING A GOLF GAME 审中-公开
标题翻译：用于模拟高尔夫游戏的系统和方法
公开(公告)号：WO2005044408A1
公开(公告)日：2005-05-19
申请号：PCT/EP2004/052893
申请日：2004-11-09
申请人： NAVARRO RODRÍGUEZ, Francisco
发明人： NAVARRO RODRÍGUEZ, Francisco
IPC分类号： A63F7/00
CPC分类号： A63F3/0005 , A63F7/0628 , A63F2003/00974 , A63F2007/3674
摘要： A game system simulating a golf game, comprising a board (1, 2) having defined thereon a golf hole (9) and a number of intermediate regions (6a, 6d) simulating golf course regions, a playing piece simulating a golf ball (14), a random-generation device (12) such as a dice for selecting at random a playing path to be followed by the playing piece (14) on the board, said path comprising at least one intermediate region and the region simulating the golf hole, and a club (13) piece simulating a golf club, appropriate to be held by a player for hitting the playing piece to make it follow the selected path, wherein the score of each player depends at least on the subsequent positions on the board in which the playing piece lands.
摘要翻译：一种模拟高尔夫游戏的游戏系统，包括在其上限定有高尔夫球孔（9）的板（1,2）和模拟高尔夫球场区域的多个中间区域（6a，6d），模拟高尔夫球（14）），诸如骰子的随机生成装置（12），用于随机选择棋盘（14）所遵循的播放路径，所述路径包括至少一个中间区域和模拟高尔夫球场的区域以及模拟高尔夫球杆的俱乐部（13），其适于由玩家持有以击球，使其跟随所选择的路径，其中每个玩家的得分至少取决于棋盘上的后续位置玩家的地盘。

34. 发明申请

WO2004110423A1 ANESTHETIC COMPOSITION FOR TOPICAL ADMINISTRATION 审中-公开
标题翻译：用于局部管理的麻醉组合物
公开(公告)号：WO2004110423A1
公开(公告)日：2004-12-23
申请号：PCT/EP2004/050967
申请日：2004-06-01
申请人： BOUFFARD FITA, Fernando
发明人： BOUFFARD FITA, Fernando
IPC分类号： A61K31/165
CPC分类号： A61K9/0014 , A61K31/165 , A61K31/167 , A61K31/245 , A61K47/20 , A61K47/22 , A61K47/32 , A61K47/36 , A61K47/42 , A61K2300/00
摘要： It comprises a mixture of lidocaine, prilocaine and tetracaine, or their pharmaceutically acceptable salts. The preferred composition comprises the following components in the indicated approximate w/w percentages: 1.5% of lidocaine base; 1.5% of prilocaine base; 4% of tetracaine base; 10% of methylpyrrolidone; 2% of dimethyl sulfoxide; 0.08% of topical hyaluronidase; 1.5% of guar gum; 1 % of Tween-20; 0.5% of Tween-80, and the necessary amount of water to 100%. It exhibits a a high concentration on skin, a deep anesthetic effect and a significantly more rapid onset of the anesthetic effect than comparable transdermal anesthetics.
摘要翻译：它包含利多卡因，丙胺卡因和丁卡因或其药学上可接受的盐的混合物。优选的组合物包含指示的近似w / w百分比的以下组分：1.5％的利多卡因碱; 丙胺卡因碱的1.5％ 4％丁卡因碱 10％甲基吡咯烷酮; 2％二甲基亚砜; 局部透明质酸酶0.08％ 1.5％的瓜尔胶; 1％Tween-20; 0.5％的Tween-80，所需量的水至100％。它表现出比类似的经皮麻醉剂高的皮肤浓度，深度麻醉效应和显着更快的麻醉效果。

35. 发明申请

WO2010142336A1 SYSTEM FOR MONITORING A PLURALITY OF CONTAINERS 审中-公开
标题翻译：监测大量集装箱的系统
公开(公告)号：WO2010142336A1
公开(公告)日：2010-12-16
申请号：PCT/EP2009/057229
申请日：2009-06-11
申请人： AIFOS SOLUTIONS, S.L. , JANÉ RIBERA, Esteve , XIOL FORET, Joan
发明人： JANÉ RIBERA, Esteve , XIOL FORET, Joan
IPC分类号： G06K7/10 , G06K19/077
CPC分类号： G06K7/10346 , G06K7/10316 , G06K19/07749 , G06K19/07767
摘要： A system for monitoring a plurality of containers which comprise at least one RFID tag each, is presented. The system uses a combination of Near Field and Far Field antennas for monitoring a plurality of RFID tags related to a plurality of containers, with the objective of counting the containers and retrieving information comprised in the RFID tags in an optimum way. The RFID tags may be used in the UHF range of frequencies and, furthermore, the system may perform the monitoring with no need of movable pieces, simplifying the construction of the overall system.
摘要翻译：提出了一种用于监视包括至少一个RFID标签的多个容器的系统。该系统使用近场和远场天线的组合来监测与多个容器相关的多个RFID标签，其目的是以最佳方式对容器进行计数和检索包含在RFID标签中的信息。 RFID标签可以在UHF频率范围内使用，此外，系统可以不需要可动件来执行监控，从而简化整个系统的结构。

36. 发明申请

WO2010072823A1 PYRAZOLE[1,5a]PYRIDINE DERIVATIVES 审中-公开
标题翻译：吡咯[1,5a]吡啶衍生物
公开(公告)号：WO2010072823A1
公开(公告)日：2010-07-01
申请号：PCT/EP2009/067883
申请日：2009-12-23
申请人： PALAU PHARMA, S. A. , SALAS SOLANA, Jorge , ALMANSA ROSALES, Carmen , COMELLES ESPUGA, Josep , FONTES USTRELL, Montserrat , SOLIVA SOLIVA, Robert , PASTOR PORRAS, José, Javier
发明人： SALAS SOLANA, Jorge , ALMANSA ROSALES, Carmen , COMELLES ESPUGA, Josep , FONTES USTRELL, Montserrat , SOLIVA SOLIVA, Robert , PASTOR PORRAS, José, Javier
IPC分类号： C07D471/04 , A61K31/437 , A61P35/00 , A61P29/00 , A61P37/06
CPC分类号： C07D471/04
摘要： Pyrazolo[1,5-a]pyridine derivatives of formula I, wherein the meaning for R 1 , R 2 and R 3 is as disclosed in the description. These compounds are useful as JAK3 kinase inhibitors.
摘要翻译：式I的吡唑并[1,5-a]吡啶衍生物，其中R1，R2和R3的含义如说明书中所公开的。这些化合物可用作JAK3激酶抑制剂。

37. 发明申请

WO2010037846A3 METHOD AND SYSTEM FOR ALIGNING A WIND TURBINE COMPONENT 审中-公开
公开(公告)号：WO2010037846A3
公开(公告)日：2010-04-08
申请号：PCT/EP2009/062822
申请日：2009-10-02
申请人： ECOTECNIA ENERGÍAS RENOVABLES, S. L. , CASTELL MARTÍNEZ, Daniel , CASANOVAS BERMEJO, Carlos
发明人： CASTELL MARTÍNEZ, Daniel , CASANOVAS BERMEJO, Carlos
IPC分类号： F03D1/00 , F03D11/02
摘要： The invention relates to a method of aligning a wind turbine component with a wind turbine rotor hub (3), characterised in that it comprises the steps of providing the component with a support comprising at least one adjustable element (20) and adjusting said at least one element to align the wind turbine component. The invention further relates to a system for aligning a wind turbine component with a wind turbine rotor hub comprising a support with at least one adjustable element (20) supporting said wind turbine component, such that said wind turbine component can be aligned by adjusting said at least one element (20).

38. 发明申请

WO2009156471A1 PROSTHETIC HEART VALVE AND METHOD FOR MAKING SUCH A VALVE 审中-公开
标题翻译：前置心脏阀和制造这种阀的方法
公开(公告)号：WO2009156471A1
公开(公告)日：2009-12-30
申请号：PCT/EP2009/057970
申请日：2009-06-25
申请人： IBERHOSPITEX, S.A. , VONDERWALDE, Carlos , PÉREZ SERRANOS, Isabel , DUOCASTELLA CODINA, Lluís , LÓPEZ RODRÍGUEZ, Aniceto
发明人： VONDERWALDE, Carlos , PÉREZ SERRANOS, Isabel , DUOCASTELLA CODINA, Lluís , LÓPEZ RODRÍGUEZ, Aniceto
IPC分类号： A61F2/24
CPC分类号： A61F2/2415 , A61F2/2409 , A61F2/2418
摘要： The present invention relates to a method of making a prosthetic heart valve comprising the steps of placing a piece of biological tissue (12) in or over a mould (10), and simultaneously tanning said tissue and shaping it to an appropriate shape. Furthermore, it relates to a prosthetic heart valve of a single piece of biological tissue, said valve comprising a cylindrical base and leaflets, characterised in that said cylindrical base and leaflets have a continuous peripheral wall.
摘要翻译：本发明涉及一种制造假体心脏瓣膜的方法，包括以下步骤：将一片生物组织（12）放置在模具（10）中或其上方，并且同时鞣制所述组织并将其成形为适当的形状。此外，它涉及单个生物组织的假体心脏瓣膜，所述瓣膜包括圆柱形基部和小叶，其特征在于，所述圆柱形基部和小叶具有连续的周壁。

39. 发明申请

WO2009147097A1 METHODS AND APPARATUS FOR SENDING DATA PACKETS TO AND FROM MOBILE NODES 审中-公开
标题翻译：向数据包发送和移动数据包的方法和装置
公开(公告)号：WO2009147097A1
公开(公告)日：2009-12-10
申请号：PCT/EP2009/056630
申请日：2009-05-29
申请人： MEDIA PATENTS, S. L. , FERNÁNDEZ GUTIÉRREZ, Álvaro
发明人： FERNÁNDEZ GUTIÉRREZ, Álvaro
IPC分类号： H04W36/00
CPC分类号： H04W12/10 , H04L63/12 , H04L63/162 , H04L63/164 , H04W36/0011 , H04W36/02 , H04W80/04
摘要： Methods for transmitting packets using a Mobile IP protocol between a mobile node and a first node in a data network after the mobile node has transmitted data packets to the first node via a first router from a first CoA or CCoA address and by a first security association with the first node. One method includes the mobile node, sending to the first node via a second router using a second CoA or CCoA address, data packets that include an identifier of the mobile node that enables the first node to identify the mobile node as the sender of the data packets during an initial time period after transmission of the data packets via the second router has started, and during the initial time period, the mobile node authenticates the data packets it transmits to the first node using the first security association with the first node.
摘要翻译：在移动节点经由第一路由器从第一CoA或CCoA地址向第一节点发送数据分组以及通过第一安全关联之后，在移动节点和数据网络中的第一节点之间使用移动IP协议来发送分组的方法与第一个节点。一种方法包括移动节点，通过使用第二CoA或CCoA地址的第二路由器向第一节点发送数据分组，数据分组包括能够使第一节点识别移动节点作为数据的发送者的移动节点的标识符已经开始通过第二路由器发送数据分组之后的初始时段期间的分组，并且在初始时间段期间，移动节点使用与第一节点的第一安全关联来向其发送的数据分组进行认证。

40. 发明申请

WO2009092716A1 CRYSTALLINE FORM OF ABACAVIR THAT IS ESSENTIALLY FREE OF SOLVENT 审中-公开
标题翻译： ABACAVIR的结晶形式基本不含溶剂
公开(公告)号：WO2009092716A1
公开(公告)日：2009-07-30
申请号：PCT/EP2009/050613
申请日：2009-01-21
申请人： ESTEVE QUÍMICA, S.A. , BARTRA SANMARTÍ, Martí , BERENGUER MAIMÓ, Ramón , BENET-BUCHHOLZ, Jordi , SOLÀ I CARANDELL, Lluís
发明人： BARTRA SANMARTÍ, Martí , BERENGUER MAIMÓ, Ramón , BENET-BUCHHOLZ, Jordi , SOLÀ I CARANDELL, Lluís
IPC分类号： C07D473/16 , A61K31/52 , A61P31/00
CPC分类号： C07D473/16
摘要： Crystalline form of abacavir that is essentially free of solvent of formula (I), in particular crystalline Form I, and its preparation process which comprises the following steps: a) crystallizing abacavir from a solution of said compound in a (C 1 -C 4 )-alcohol, dichloromethane, acetonitrile/water, or mixtures thereof; b) isolating the crystalline form of abacavir that appears in the prior step; and c) removing the solvent from the crystalline form of abacavir thus obtained. Crystalline Form I can also be obtained by dispersion of abacavir in acetonitrile. The crystalline form of abacavir that is essentially free of solvent is useful for the preparation of pharmaceutical compositions for use in the treatment and/or prophylaxis of HIV infections.
摘要翻译：结晶形式的阿巴卡韦，基本上不含式（I）的溶剂，特别是结晶形式I及其制备方法，其包括以下步骤：a）将所述化合物在（C1-C4） - 醇，二氯甲烷，乙腈/水或其混合物; b）分离出现在先前步骤中的阿巴卡韦的结晶形式; 和c）从由此获得的阿巴卡韦的结晶形式除去溶剂。结晶形式I也可以通过将阿巴卡韦分散在乙腈中获得。基本上不含溶剂的阿巴卡韦的结晶形式可用于制备用于治疗和/或预防HIV感染的药物组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式